Bosentan - Latest Advances

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline.

Journal: eLife

Published: September 09, 2025

In brief: Embryotoxicity REMS removal for endothelin receptor antagonists.

Journal: The Medical letter on drugs and therapeutics

Published: September 09, 2025

Dual Endothelin Receptor Inhibition with Bosentan Does Not Prevent the Early Formation of Post-Traumatic Joint Contracture in a Rat Model.

Journal: Journal of clinical medicine

Published: August 19, 2025

Predicting Food Effect On Oral Drug Absorption For Solubility-Epithelial Membrane Permeation-Limited Cases With Bile Micelle Solubilization.

Journal: Pharmaceutical research

Published: August 14, 2025

Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.

Journal: The Cochrane database of systematic reviews

Published: August 04, 2025

Neuronal Endothelin a Receptor Mediates Experimental and Clinical Vascular Pain through an Endothelial-Neural Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 05, 2025

Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia-Reperfusion Injury.

Journal: Medicina (Kaunas, Lithuania)

Published: June 30, 2025

Causal Inference of Adverse Drug Events in Pulmonary Arterial Hypertension: A Pharmacovigilance Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 12, 2025

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Deciphering molecular overlaps between COPD and NSCLC subtypes (LUAD and LUSC): An integrative bioinformatics study.

Journal: Medicine

Published: May 23, 2025

Update Raynaud Phenomenon

Journal: Deutsche medizinische Wochenschrift (1946)

Published: May 19, 2025

Pre-Formulation Studies of Lipid-Based Formulation Approach for a Poorly Water-Soluble Biopharmaceutics Classification System Class II Model Drug: Bosentan.

Journal: Turkish journal of pharmaceutical sciences

Published: May 14, 2025

Filters

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline.

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline.

In brief: Embryotoxicity REMS removal for endothelin receptor antagonists.

In brief: Embryotoxicity REMS removal for endothelin receptor antagonists.

Dual Endothelin Receptor Inhibition with Bosentan Does Not Prevent the Early Formation of Post-Traumatic Joint Contracture in a Rat Model.

Dual Endothelin Receptor Inhibition with Bosentan Does Not Prevent the Early Formation of Post-Traumatic Joint Contracture in a Rat Model.

Predicting Food Effect On Oral Drug Absorption For Solubility-Epithelial Membrane Permeation-Limited Cases With Bile Micelle Solubilization.

Predicting Food Effect On Oral Drug Absorption For Solubility-Epithelial Membrane Permeation-Limited Cases With Bile Micelle Solubilization.

Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.

Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.

Neuronal Endothelin a Receptor Mediates Experimental and Clinical Vascular Pain through an Endothelial-Neural Axis.

Neuronal Endothelin a Receptor Mediates Experimental and Clinical Vascular Pain through an Endothelial-Neural Axis.

Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia-Reperfusion Injury.

Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia-Reperfusion Injury.

Causal Inference of Adverse Drug Events in Pulmonary Arterial Hypertension: A Pharmacovigilance Study.

Causal Inference of Adverse Drug Events in Pulmonary Arterial Hypertension: A Pharmacovigilance Study.

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline.

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline.

Deciphering molecular overlaps between COPD and NSCLC subtypes (LUAD and LUSC): An integrative bioinformatics study.

Deciphering molecular overlaps between COPD and NSCLC subtypes (LUAD and LUSC): An integrative bioinformatics study.

Update Raynaud Phenomenon

Update Raynaud Phenomenon

Pre-Formulation Studies of Lipid-Based Formulation Approach for a Poorly Water-Soluble Biopharmaceutics Classification System Class II Model Drug: Bosentan.

Pre-Formulation Studies of Lipid-Based Formulation Approach for a Poorly Water-Soluble Biopharmaceutics Classification System Class II Model Drug: Bosentan.